Ascendis Pharma AS (MEX:ASNDN) Total Liabilities: MXN31,590 Mil (As of Mar. 2026)


MEX:ASNDN Ascendis Pharma AS MEX:ASNDN
37 GF Score
Price MXN3,851.44
! 1 Warning Sign
View Full Analysis

What is Ascendis Pharma AS Total Liabilities?

Ascendis Pharma AS MEX:ASNDN 37 Total Liabilities is MXN31,590 Mil as of Mar. 2026. GuruFocus rates MEX:ASNDN with a GF Score™ of 37/100. The stock has 1 warning sign investors should review.

Ascendis Pharma AS's Total Liabilities for the quarter that ended in Mar. 2026 was MXN31,590 Mil.

Ascendis Pharma AS's quarterly Total Liabilities increased from Sep. 2025 (MXN28,610.60 Mil) to Dec. 2025 (MXN30,896.24 Mil) and increased from Dec. 2025 (MXN30,896.24 Mil) to Mar. 2026 (MXN31,589.66 Mil).

Ascendis Pharma AS's annual Total Liabilities increased from Dec. 2023 (MXN17,979.08 Mil) to Dec. 2024 (MXN28,066.77 Mil) and increased from Dec. 2024 (MXN28,066.77 Mil) to Dec. 2025 (MXN30,896.24 Mil).

Ascendis Pharma AS Total Liabilities Historical Data

* Premium members only.

The historical data trend for Ascendis Pharma AS's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ascendis Pharma AS Total Liabilities Chart

Ascendis Pharma AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,665.74 17,067.05 17,979.08 28,066.77 30,896.24

Ascendis Pharma AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27,673.75 27,700.29 28,610.60 30,896.24 31,589.66
MEX:ASNDN
37GF Score
Ascendis Pharma AS MEX:ASNDN
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ascendis Pharma AS Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Ascendis Pharma AS's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=22546.995+(8122.679+-7.105427357601E-13
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+226.568+0+0)
=30,896

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=27463.331--3432.911
=30,896

Ascendis Pharma AS's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=23489.687+(8049.172+-8.2422957348172E-13
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+50.804+0+0)
=31,590

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=41762.462-10172.799
=31,590

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of MXN31,590 Mil mean?
Ascendis Pharma AS (MEX:ASNDN) has a Total Liabilities of MXN31,590 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Ascendis Pharma AS and its competitors.
Is Ascendis Pharma AS's Total Liabilities too high?
Ascendis Pharma AS's current Total Liabilities is MXN31,590 Mil. Overall, Ascendis Pharma AS has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Ascendis Pharma AS's Total Liabilities compare to SMMT and BBIO?
Ascendis Pharma AS's Total Liabilities of MXN31,590 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Ascendis Pharma AS and its competitors. Ascendis Pharma AS's current Total Liabilities is MXN31,590 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascendis Pharma AS stock overvalued right now?
Ascendis Pharma AS (MEX:ASNDN) has a current Total Liabilities of MXN31,590 Mil. The current Total Liabilities is MXN31,590 Mil. Ascendis Pharma AS's overall GF Score™ is 37/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Ascendis Pharma AS (MEX:ASNDN), the current Total Liabilities is MXN31,590 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ascendis Pharma AS Business Description

Other Exchanges ASND:USA
Address Tuborg Boulevard 12, Hellerup, DNK, 2900
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
37GF Score

Get the complete analysis for MEX:ASNDN

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN3,851.44
Price